News Releases from 2022
Nanoengineers receive $4.3M from NIH to continue studies using plant viruses to treat cancer
Researchers led by Nicole Steinmetz, professor of nanoengineering at the University of California San Diego, have received $4.3 million in grants from the National Institutes of Health (NIH) to advance their research using plant viruses to develop cancer immunotherapies. Full Story
San Diego Union-Tribune previews opening of Franklin Antonio Hall
Just weeks before the grand opening on Sept. 23, the San Diego Union-Tribune published an extensive story about Franklin Antonio Hall, the latest building at the UC San Diego Jacobs School of Engineering. The sleek and soaring structure is located across the street from to Atkinson Hall, near the campus’ Warren College neighborhood. Full Story
Plant virus plus immune cell-activating antibody clear colon cancer in mice, prevent recurrence
A new combination therapy to combat cancer could one day consist of a plant virus and an antibody that activates the immune system’s “natural killer” cells, shows a study by researchers at the University of California San Diego. In mouse models of colon cancer, the combination therapy eliminated all tumors and prevented their recurrence, which in turn resulted in 100% survival. The therapy also increased survival in mouse models of melanoma. Full Story
Researchers shed light on why a certain plant virus is so powerful at fighting cancer
The cowpea mosaic virus has shown great promise as an experimental cancer immunotherapy for treating and preventing recurrence of various cancers. But just how the virus triggers such a potent anti-cancer immune response has remained a mystery. A new study digs deeper and provides answers. Full Story